Thai govt purge indicates CL shift
Thailand's Public Health Minister Chaiya Sasomsub is allegedly putting pressure on Vichai Chokewiwat, a key supporter of the country's compulsory licensing (Marketletters passim) policy, to resign as chairman of the Government Pharmaceutical Organisation. Mr Chaiya told the Bangkok Post that "different ministers have different policies."
The GPO is responsible for importing seven HIV/AIDS, cardiovascular and cancer drugs listed under the compulsory license policy announced by the previous military-supported government. However, Mr Chaiya had already shelved plans to grab patents for the oncology products.
Dr Vichai's removal would shortly follow that of Siriwat Tiptaradol, Secretary General of Thailand's Food and Drug Administration, who, the Bangkok Post reported, has been transferred to an "inactive post as a health ministry inspector."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze